Michael D. West
BioTime, Inc., USA
Biography
Michael D West is the Chief Executive Officer of BioTime, Inc. (NYSE-MKT: BTX) and its subsidiary AgeX Therapeutics. The companies are focused on developing therapeutic products using human embryonic stem cells. He received his PhD from Baylor College of Medicine and has focused his academic and business career on the application of developmental biology to the age-related degenerative disease. He was previously the Founder of Geron Corporation (NASDAQ: GERN), where he initiated and managed programs in telomere biology and human embryonic stems and later CEO at ACT (Ocata) (NASDAQ: OCAT) managing programs in somatic cell nuclear transfer and cell-based retinal therapeutics.
Abstract
Abstract : The use of pluripotency in the manufacture of advanced cell-based tissue-engineered therapeutics